Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|August 6, 2019
Etiologies of Extreme Thrombocytosis: A Contemporary SeriesRonan W Hsieh, Aishwarya Ravindran, Christopher C Hook, et al.
Cancer|December 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemiaTalha Badar, Mark R Litzow, Rory M Shallis, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 11, 2019
TonEBP-deficiency accelerates intervertebral disc degeneration underscored by matrix remodeling, cytoskeletal rearrangements, and changes in proinflammatory gene expressionSteven Tessier, Victoria A Tran, Olivia K Ottone, et al.
American Journal of Hematology|February 18, 2026
TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast-Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating AgentNaseema Gangat, Momna Warraich, Sudhesh Kumar, et al.
American Journal of Hematology|January 28, 2025
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic RelevanceAyalew Tefferi, Maymona Abdelmagid, Giuseppe G Loscocco, et al.
Hematological Oncology|August 29, 2018
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndromeChristopher B Benton, Kelly S Chien, Ayalew Tefferi, et al.
Haematologica|May 21, 2026
Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significanceYazan Jabban, Rong He, Kurt Bessonen, et al.
Haematologica|July 9, 2026
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutationsMahmoud Yacout, Bahga Katamesh, Yazan Jabban, et al.
Haematologica|July 17, 2025
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatmentOudai Alkabbani, Yazan Jabban, Rong He, et al.
Ejhaem|December 17, 2025
Blast Clearance Dynamics and Time to Response Across IDH1- and IDH2-Mutated AMLMohamad Sheikh Najeeb, Oudai Alkabbani, Rong He, et al.
Pageof 18